Decitabine 20 mg/m²/day for 5 days

DRUG2 trials

Sponsors

Chinese PLA General Hospital, The Methodist Hospital Research Institute

Conditions

AMLAcute Myeloid Leukaemia (AML)Acute Myeloid Leukemia (AML)

Phase 2

Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML

CompletedNCT02662647

Chinese PLA General HospitalAML

Start: 2015-04-30End: 2019-03-31Updated: 2019-06-10

Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker

Not yet recruitingNCT07060001

The Methodist Hospital Research InstituteAcute Myeloid Leukaemia (AML), Acute Myeloid Leukemia (AML)

Start: 2026-04-01End: 2029-12-01Target: 112Updated: 2026-03-06